A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 187, Issue 5, 2003, Pages 725-735

  Moodley, Dhayendre ^a   Moodley, Jagidesa ^a   Coovadia, Hoosen ^a   Gray, Glenda ^f   McIntyre, James ^f   Hofmyer, Justus ^b   Nikodem, Cheryl ^b   Hall, David ^d   Gigliotti, Maria ^d   Robinson, Patrick ^d   Boshoff, Lynette ^c   Sullivan, John L ^e  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Boehringer Ingelheim   (South Africa)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROENTERITIS; HEPATOMEGALY; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION; INFECTION PREVENTION; INSTITUTIONAL CARE; LABOR; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE DRUG DOSE; NEWBORN JAUNDICE; NONHUMAN; PERINATAL ASPHYXIA; PERINATAL PERIOD; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT DISEASE; SCREENING; SIDE EFFECT; SOUTH AFRICA; UTERUS; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LABOR, OBSTETRIC; LAMIVUDINE; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0037333802     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/367898     Document Type: Article

References (28)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. Pediatric AIDS Clinical Trials Protocol 076 Study Group. N Engl J Med 1994; 331:1173-80.
2. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother to child transmission of HIV-1 in Abidjan, Cote d' Ivoire. Lancet 1999; 353:781-5.
3. Shaffeŕ N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353:773-80.
4. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother to child transmission of HIV-1 in Kampala, Uganda: HIV-1NET 012 randomised trial. Lancet 1999; 354:795-802.
5. Dabis F, Msellati P, Meda N, et al. 6-Month efficacy, tolerance, and acceptability, of a short regimen of oral zidovudine to reduce vertical transmission of HIV-1 in breastfed children in Cote d' Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353:786-92.
6. Petra Study Team. Efficacy of three short course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised double-blind, placebo-controlled trial. Lancet 2002; 359:1178-86.
7. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV-1 Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343:982-91.
8. Mofenson LM. Mother-child HIV-1 transmission: timing and determinants. Obstet Gynecol Clin North Am 1997; 24:759-84.
9. Bertolli J, St Louis ME, Simonds RJ, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breastfeeding population in Kinshasha, Zaire. J Infect Dis 1996; 174:722-6.
10. Mock PA, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child transmission, Bangkok, Thailand. AIDS 1999; 13:407-14.
11. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV-1 transmission in resource poor countries: translating research into policy and practice. JAMA 2000; 283:1175-82.
12. Owor M, Deseyve M, Duefield C, et al. The one-year safety and efficacy data of HIV-1NET 012 trial [abstract LbOr1]. In: XIII International AIDS Conference (Durban, South Africa), 2000.
13. World Health Organization (WHO). Coverage of maternal care: a listing of available information. 4th ed. Geneva: WHO, 1997.
14. International Perinatal HIV-I Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a data analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977-87.
15. Bryson Y, Luzuriaga K, Sullivan J, Wara D. Proposed definition from in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327:1246-7.
16. Reisler RB, Thea DM, Pliner V, et al. Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction. J Acquir Immune Defic Syndr 2001; 26:93-102.
17. Young NL, Shaffer N, Chaowanachan T, et al. Early diagnosis of HIV-1 infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr 2000; 24:401-7.
18. Lyamuya E, Olausson-Hansson E, Albert J, Mahlu F, Biberfeld G. Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C, and D. J Clin Virol 2000; 17:57-63.
19. Van Rompay KKA, Dailey PJ, Tarara RP, et al. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl] adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol 1999; 73:2947-55.
20. Labbock M, Krasovec K. Towards consistency in breastfeeding definition. Stud Fam Plann 1999; 21:226-30.
21. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding patterns in early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet 1999; 354:471-6.
22. World Health Organization (WHO) Technical Consultation on Behalf of file NFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV-1. New data on the prevention of mother-to-child transmission of HIV-1 and their policy implications: conclusions and recommendations. Geneva, WHO: 2000.
23. Leroy V, Karon JM, Alioum A, et al. Twenty-four month efficacy of a maternal short-zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002; 16:631-41.
24. Mofenson L. Review of recent perinatal trials. HIV-I Prevention Trials Network (HPTN). Washington DC, National Institutes of Health: 2000.
25. Katzenstein DA, Mbizvo M, Zijenah L, et al. Serum level of maternal human immunodeficiency virus (HIV-1) RNA, infant mortality, and vertical transmission of HIV-1 in Zimbabwe. J Infect Dis 1999; 179:1382-7.
26. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV-1 transmission from mother to infant. JAMA 2001; 285:709-712.
27. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomised clinical trial. JAMA 2000; 283:1167-74.
28. Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET-012). AIDS 2001; 15:1951-7.